Homepage
Products
A well-balanced and diversified product portfolio
In both its targeted therapeutic areas and in primary care, Ipsen has a diversified portfolio of leading medicines that have demonstrated a good safety profile.
The Group's product portfolio includes pharmaceutical products marketed around the world to specialists working in its targeted therapeutic areas (oncology, endocrinology and neuromuscular disorders), which are its primary areas of development. The Group also markets products in other therapeutic areas in which it boasts longstanding expertise (gastroenterology, cardiovascular and cognitive disorders). To a great extent, these are composed of primary care. Targeted therapeutic areas
Oncology: Decapeptyl®
Endocrinology: Somatuline®, NutropinAq®, Increlex®
Neurology: Dysport®
Primary care
Gastroenterology: Smecta®, Forlax®
Cognitive disorders: Tanakan®
Cardiovascular: Nisis® & Nisisco®
